- Mesoblast press release (NASDAQ:MESO): Q2 net operating cash spend was $10.1 million.
- Net operating cash spend for the quarter was reduced by 18% ($2.2 million) versus the prior comparative quarter in FY2024.
- Cash on hand at the end of the quarter was $38 million (A$61 million) with pro-forma cash after proceeds raised in January of approximately $200 million (A$322 million).